EN
HI
Suven Life Sciences share price chart
Suven Life Sciences Share Key Metrics
Volume
5.40 L
Market Cap
9495.26 CR
LTQ@LTP
75@360.05
ATP
364.15
Var Margin
100 %
Circuit Range
295.8-443.7
Delivery %
38.47 %
Value
19.68 CR
ASM/GSM
No
Market Lot
1
Summary
SUVEN stock price is ₹360.05 as of 25 Aug, 2026. The stock intraday movement has stayed between ₹356.65 and ₹374.80, while Suven Life Sciences share price 52 week high low is ₹124.11 & ₹393.50.
In terms of trading activity, SUVEN share price has recorded a volume of 5,40,439 shares. The Suven Life Sciences has a market cap of ₹263720583. The stock’s Average Traded Price (ATP) stands at ₹364.15, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 75 @ ₹360.05.
The Suven Life Sciences upper circuit limit is ₹443.70 & The Suven Life Sciences lower circuit limit is ₹295.80, with a Value of ₹19.68 CR. The Delivery Percentage for the day is 38.47%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Suven Life Sciences Fundamentals
P/E Ratio
0
P/B Ratio
18.78
Div. Yield
0
Sector P/E
69.22
Sector P/B
3.36
Sec. Div. Yield
0.51
Suven Life Sciences Resistance and Support
Pivot 376.48
Resistance
First Resistance
386.76
Second Resistance
403.78
Third Resistance
414.06
Support
First Support
359.46
Second Support
349.18
Third Support
332.16
Suven Life Sciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 25 2026 | 367 | 360.05 | -2.62% | 374.8 | 356.65 |
| Mon Aug 24 2026 | 374 | 369.75 | -0.91% | 393.5 | 366.2 |
| Fri Aug 21 2026 | 377 | 373.14 | -0.12% | 389.89 | 361.39 |
Suven Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-13 | Audited Results |
| 2026-01-29 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-05-13 | Audited Results & Preferential issue |
| 2025-01-24 | Quarterly Results |
| 2024-10-29 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
Suven Life Sciences News
Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Suven Life Sciences received the Monitoring Agency Report from CRISIL Ratings Limited for Q1 FY27. The report confirms that the proceeds from the preferential issue have been utilized as per the disclosed objects, with no deviations observed.
Aug 11 2026 12:33:40
Suven Life Sciences Ltd - 530239 - Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 30, 2026
Suven Life Sciences reported a significant widening of its consolidated net loss for Q1 FY27 to ₹127.61 crores, compared to ₹51.52 crores in Q1 FY26. Revenue for the quarter was ₹110.89 crores. The company also announced progress in its clinical development pipeline, including 95% enrollment in the SUVN-502 Global Phase 3 trial.
Aug 06 2026 12:50:24
Read More
Suven Life Sciences Management
| Name | Position |
|---|---|
| Venkateswarlu Jasti | Chairman & Managing Director |
| Seyed E Hasnain | Non Executive Director |
Suven Life Sciences Similar Stocks
Sanofi Consumer Healthcare India Ltd.
4176.90
-43.70 (1.04%)
Blue Jet Healthcare Ltd.
589.15
0.35 (0.06%)
Metropolis Healthcare Ltd.
566.70
3.35 (0.59%)
Healthcare Global Enterprises Ltd.
724.85
6.05 (0.84%)
Jupiter Life Line Hospitals Ltd.
298.70
-9.15 (2.97%)
Strides Pharma Science Ltd.
986.60
-7.00 (0.70%)
Thyrocare Technologies Ltd.
596.05
12.05 (2.06%)
Procter & Gamble Health Ltd.
5833.00
-40.50 (0.69%)
Yatharth Hospital & Trauma Care Services Ltd.
923.05
15.50 (1.71%)
Suven Life Sciences FAQs
The Buying Price of Suven Life Sciences share is 360.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Suven Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Suven Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Suven Life Sciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Suven Life Sciences shares is 18.78. Useful to assess the stock's value relative to its book value.
To assess Suven Life Sciences’s valuation compare Sector P/E, P/B which are 69.22 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Suven Life Sciences is 9495.26 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Suven Life Sciences share price is 393.50 & 124.11. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Suven Life Sciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
